Clinical Trial, FDA Approval, User Metrics Misrepresentation Suits Filed
Recent securities class action and shareholder derivative lawsuits filed in federal courts across the country include complaints alleging misrepresentation of clinical trial results for a bladder cancer treatment drug, growth in...To view the full article, register now.
Already a subscriber? Click here to view full article